Developments in the pharmacotherapeutic management of spontaneous preterm labor (Q37142064)

18 August 2017

1 reference

title

Developments in the pharmacotherapeutic management of spontaneous preterm labor (English)

1 reference

18 August 2017

1 reference

K Y Ronald Kam

1

1 reference

18 August 2017

Ronald F Lamont

series ordinal

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

Expert Opinion on Pharmacotherapy

18 August 2017

published in

1 reference

18 August 2017

volume

9

1 reference

18 August 2017

issue

7

1 reference

18 August 2017

page(s)

1153-1168

1 reference

Neurologic and developmental disability after extremely preterm birth. EPICure Study Group.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

New perspectives for the effective treatment of preterm labor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Guidelines for the management of spontaneous preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Mechanisms underlying "functional" progesterone withdrawal at parturition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Interactions between progesterone receptor isoforms in myometrial cells in human labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Myometrial progesterone responsiveness and the control of human parturition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Prostaglandin inhibitors in preterm labour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

NF-kappa B activation as a pathological mechanism of septic shock and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

The role of nuclear factor kappa B in human labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Phosphodiesterase-4 as a potential drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Animal models of antenatal corticosteroids: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Preterm betamethasone treatment of fetal sheep: outcome after term delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Effects of betamethasone administration to the fetal sheep in late gestation on fetal cerebral blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Long term effects of antenatal betamethasone on lung function: 30 year follow up of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Effects of a single course of corticosteroids given more than 7 days before birth: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Repeated antenatal corticosteroids: size at birth and subsequent development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Neonatal adrenal function after repeat dose prenatal corticosteroids: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Effects of prenatal betamethasone exposure on regulation of stress physiology in healthy premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Antenatal corticosteroids revisited: repeat courses - National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Biochemistry and pharmacology of the myometrium and labor: regulation at the cellular and molecular levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Tocolytics for preterm labor: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Ritodrine- and terbutaline-induced hypokalemia in preterm labor: mechanisms and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Rebound hyperkalemia after cessation of intravenous tocolytic therapy with terbutaline in the treatment of preterm labor: anesthetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Rebound perioperative hyperkalemia in six patients after cessation of ritodrine for premature labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Changes in fetal hemodynamics with ritodrine tocolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Transient electrocardiographic changes suggesting myocardial ischaemia in newborn infants following tocolysis with beta-sympathomimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Severe hyperinsulinaemic hypoglycaemia in a baby born to a mother taking oral ritodrine therapy for preterm labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Oxytocin Receptors and Human Parturition: A Dual Role for Oxytocin in the Initiation of Labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

The development and introduction of anti-oxytocic tocolytics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Treatment of preterm labor with the oxytocin antagonist atosiban

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Calcium channel blockers in the management of preterm labor and hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Prevention of preterm delivery: nifedipine or magnesium sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Nifedipine versus terbutaline in management of preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Nifedipine versus ritodrine for suppression of preterm labor; a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

The quality of nifedipine studies used to assess tocolytic efficacy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Pulmonary edema induced by calcium-channel blockade for tocolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Acute pulmonary oedema during nicardipine therapy for premature labour; Report of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Myocardial infarction during nifedipine therapy for preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Acute myocardial infarction during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Calcium channel blockers as tocolytics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Identical phalangeal defects induced by phenytoin and nifedipine suggest fetal hypoxia and vascular disruption behind phenytoin teratogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Comparative study of the effects of two tocolytic agents (magnesium sulfate and alcohol) on the ionic transfer through the isolated human amnion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Magnesium sulfate tocolysis: time to quit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Is tocolytic magnesium sulphate associated with increased total paediatric mortality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Umbilical cord serum ionized magnesium level and total pediatric mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Prostaglandin endoperoxide H synthase inhibitors and other tocolytics in preterm labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

A double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Neonatal complications after the administration of indomethacin for preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Antenatal indomethacin--adverse fetal effects confirmed

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Nitric oxide synthase activity in the pregnant uterus decreases at parturition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

A decline in myometrial nitric oxide synthase expression is associated with labor and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

The Randomized Nitric Oxide Tocolysis Trial (RNOTT) for the treatment of preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Atosiban and nifedipine in acute tocolysis: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

Atosiban and nifedipin for the treatment of preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

The effect of relcovaptan (SR 49059), an orally active vasopressin V1a receptor antagonist, on uterine contractions in preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.7.1153

10.1517/14656566.9.7.1153

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference